抗生物質耐性

Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells

Goormaghtigh F, Fraikin N, Putrinš M, Hallaert T, Hauryliuk V, Garcia-Pino A, Sjödin A, Kasvandik S, Udekwu K, Tenson T...

2021.11.18

viable but non-culturable: VBNC抗生物質耐性

Buzzo JR, Devaraj A, Gloag ES, Jurcisek JA, Robledo-Avila F, Kesler T, Wilbanks K, Mashburn-Warren L, Balu S, Wickham J...

2021.11.14

バイオフィルム抗生物質耐性

Orman MA, Brynildsen MP. Nat Commun. 2015 Aug 6;6:7983. doi: 10.1038/ncomms8983. Erratum in: Nat Commun. 2016;7:...

2021.11.11

viable but non-culturable: VBNC抗生物質耐性

Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. BMC Microbiol. 2006 Jun 12;6:53. doi: 10.1186/1471-21...

2021.07.30

viable but non-culturable: VBNC抗生物質耐性

Dörr T, Vulić M, Lewis K. PLoS Biol. 2010 Feb 23;8(2):e1000317. doi: 10.1371/journal.pbio.1000317. PMID: 201862...

2021.07.29

viable but non-culturable: VBNC抗生物質耐性

Kawano A, Yamasaki R, Sakakura T, Takatsuji Y, Haruyama T, Yoshioka Y, Ariyoshi W. Front Cell Infect Microbiol. 202...

2021.07.28

UV殺菌抗生物質耐性

Yamasaki R, Song S, Benedik MJ, Wood TK. iScience. 2020 Jan 24;23(1):100792. doi: 10.1016/j.isci.2019.100792. E...

2021.07.27

viable but non-culturable: VBNC抗生物質耐性

Cui P, Niu H, Shi W, Zhang S, Zhang W, Zhang Y. Front Microbiol. 2018 Mar 6;9:413. doi: 10.3389/fmicb.2018.0041...

2021.07.26

viable but non-culturable: VBNC抗生物質耐性

Yu J, Liu Y, Yin H, Chang Z. Cell Discov. 2019 Jan 22;5:8. doi: 10.1038/s41421-019-0080-3. PMID: 30675381; PMCI...

2021.06.09

viable but non-culturable: VBNC抗生物質耐性

Pan Y, Zeng J, Li L, Yang J, Tang Z, Xiong W, Li Y, Chen S, Zeng Z. mSystems. 2020 Jun 2;5(3):e00821-19. doi: 1...

2021.01.31

抗生物質耐性進化